Clinical Trial Update: Optimal Timing of Ketamine Initiation for SCD Pain [Phase 3]

View source ↗

Summary

Phase 3 trial on ketamine initiation timing for pain management in sickle cell disease is not yet recruiting, indicating an upcoming study rather than results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Crisis
• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Sickle Cell Disease, Sickle Cell Crisis | Phase 3 | Status: NOT_YET_RECRUITING